hr

Hot Keywords
non-alcoholic fatty liver disease epidemiology microenvironment nonalcoholic steatohepatitis transplantation cholangiocarcinoma direct-acting antiviral immunotherapy hepatitis B hepatitis C liver resection imaging cancer stem cell diagnosis gene cirrhosis biomarker recurrence

Top
Topic: Do Standard Toxicology Parameters Match Clinical Needs for Immune Check-point Inhibitors in Liver Cancer Therapy?

A special issue of Hepatoma Research

ISSN 2454-2520 (Online), ISSN 2394-5079 (Print)

Submission deadline: 15 Mar 2022

Guest Editor(s)

  • Giuliano Ramadori, MD
    Professor of medicine, Gastroenterology and Endocrinology, University Medical Center Göttingen, Göttingen, Germany.

    Website | E-mail

  • Alessandro Ortenzi
    Doctor, Phase 1 Clinical Trials QA Coordinator - Ospedali Riuniti Ancona - Umberto I G.M. Lancisi G. Salesi, Clinical Trial Quality Assurance, United Hospitals of Ancona, Ancona, Marches, Italy.

    Website | E-mail

Submission Deadline

15 Mar 2022

Submission Information

Articles of special issue are free of charge for article processing.
For Author Instructions, please refer to http://hrjournal.net/pages/view/author_instructions
For Online Submission, please login at https://oaemesas.com/login?JournalId=hr&SpecialIssueId=hr211026
Submission Deadline: 15 Mar 2022
Contacts: Victoria Lee, Assistant Editor, editor_Victoria@hrjournal.net

Published Articles

This special issue is now open for submission.
© 2016-2021 OAE Publishing Inc., except certain content provided by third parties